An Analytical Method to Monitor Dietary Fat Intake
By LabMedica International staff writers Posted on 25 May 2020 |

Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)
An advanced analytical technique was used to determine unequivocally the composition of fats in the diets of pregnant women and female patients suspected of being deficient in certain dietary fats.
Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.
Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.
The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.
For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.
Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.
In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.
"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"
The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.
Related Links:
McMaster University
Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.
Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.
The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.
For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.
Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.
In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.
"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"
The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.
Related Links:
McMaster University
Latest Molecular Diagnostics News
- RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
- First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
- Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
- Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
- Blood Test Rules Out Future Dementia Risk
- D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
- New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
- Chemiluminescence Immunoassays Support Diagnosis of Alzheimer’s Disease
- Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury
- Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression
- Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
- Rapid Diagnostic Test to Halt Mother-To-Child Hepatitis B Transmission
- Simple Urine Test Could Help Patients Avoid Invasive Scans for Kidney Cancer
- New Bowel Cancer Blood Test to Improve Early Detection
- Refined Test Improves Parkinson’s Disease Diagnosis
- New Method Rapidly Diagnoses CVD Risk Via Molecular Blood Screening
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more